Inovio Biomedical Corporation http://www.alacrastore.com/company-snapshot/Inovio_Biomedical_Corporation-1088257 Monday, September 08, 2008 1:23:08 PM 1088257 Inovio Biomedical Corporation en AlacraStore RSS Builder 1.0 30 US - Inovio Biomedical Corp (IB) definitively agreed to acquire all the outstanding stock of VGX Pharmaceuticals Inc (VP), a biopharmaceutical company, in exchange for an undisclosed IB common stock. The transaction was subject to shareholders and regulatory approvals and other customary closing conditions. Upon completion, IB will change its name to VP.7/9/2008 2:30:33 PM45773H91930Y45773H91930YInovio Biomedical CorpVGX Pharmaceuticals IncInovio Biomedical CorpVGX Pharmaceuticals Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Inovio_Biomedical_Corp_acquires_VGX_Pharmaceuticals_Inc-1993937020sdc/19939370201993937020Copyright © 2008, Thomson Financial, All Rights ReservedAmericanMeasuring, Medical, Photo Equipment; ClocksUnited StatesSurgical and medical instruments and apparatus3841CACaliforniaPublicINO2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatusDrugsUnited StatesPharmaceutical preparations2834PAPennsylvaniaPrivate295654002Mnfr DNA vaccinesBiopharm coCommon StockStock62476001Jul 9 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000US31 Mar 080.00000-0.24000-10.155000.000004.9570035.71700U.S. Dollar0.000001.000002.000003.000004.000005.000006.000007.00000Inovio Biomedical Corp,headquartered in San Diego,California, manufacturesDNA-based immunotherapies andelectroporation-based DNAvaccine. The company wasfounded in 1983.Inovio Biomedical Corp, headquartered in San Diego,California, manufactures DNA-based immunotherapies andelectroporation-based DNA vaccine. The company was foundedin 1983.Inovio Biomedical Corp, headquartered in San Diego, California, manufactures DNA-based immunotherapies and electroporation-based DNA vaccine. The company was founded in 1983.1.000002.000003.000004.000005.000006.000007.000008.000009.00000VGX Pharmaceuticals Inc,headquartered in Blue Bell,Pennsylvania, is abiopharmaceutical company withsmall molecule and biologicproduct candidates for thetreatment of infectiousdiseases, cancer, andinflammatory diseases.VGX Pharmaceuticals Inc, headquartered in Blue Bell,Pennsylvania, is a biopharmaceutical company with smallmolecule and biologic product candidates for the treatmentof infectious diseases, cancer, and inflammatory diseases.VGX Pharmaceuticals Inc, headquartered in Blue Bell, Pennsylvania, is a biopharmaceutical company with small molecule and biologic product candidates for the treatment of infectious diseases, cancer, and inflammatory diseases.0.000000.000000.000000.00000N07 Jul 08Mon, 07 Jul 2008 00:00:00 ESTDate Announced: 07/07/2008Date Effective:MergerFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.0000057.037000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000US - Inovio Biomedical Corp(IB) definitively agreed toacquire all the outstandingstock of VGX PharmaceuticalsInc (VP), a biopharmaceuticalcompany, in exchange for anundisclosed IB common stock.The transaction was subject toshareholders and regulatoryapprovals and other customaryclosing conditions. Uponcompletion, IB will change itsname to VP.US - Inovio Biomedical Corp (IB) definitively agreed to acquire all the outstanding stock of VGX Pharmaceuticals Inc (VP), a biopharmaceutical company, in exchange for an undisclosed IB common stock. The transaction was subject to shareholders and regulatory approvals and other customary closing conditions. Upon completion, IB will change its name to VP.US - Inovio Biomedical Corp (IB) definitively agreed to acquire all the outstanding stockof VGX Pharmaceuticals Inc (VP), a biopharmaceutical company, in exchange for anundisclosed IB common stock. The transaction was subject to shareholders and regulatoryapprovals and other customary closing conditions. Upon completion, IB will change its nameto VP.US - Inovio Biomedical Corp (IB) definitively agreed to acquire all the outstanding stock of VGX Pharmaceuticals Inc (VP), a biopharmaceutical company, in exchange for an undisclosed IB common stock.The transaction was subject to shareholders and regulatory approvals and other customary closing conditions. Upon completion, IB will change its name to VP.US - Inovio Biomedical Corp (IB) definitively agreed to acquire all the outstanding stock of VGX Pharmaceuticals Inc (VP), abiopharmaceutical company, in exchange for an undisclosed IB common stock. The transaction was subject to shareholders and regulatoryapprovals and other customary closing conditions. Upon completion, IB will change its name to VP.$ 0.000 - Oppenheimer & Co Inc - Adv0.00000Oppenheimer & Co Inc1.00000Needham & Co Inc1.00000$ 0.000 - Needham & Co Inc - Adv0.00000Pending27.59900-10.155004.9570035.717000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances295654002AmericanUnited States3841CaliforniaPublicINO2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances62476001United States2834PennsylvaniaPrivate0.000000.000000.000000.00000Duane Morris LLPDeal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T1895592ccbn/T1895592norm...Welcome to today's conference call. During this presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded and will be available on Inovio's website. I would now like to turn the conference over to Mr. Bernie Hertel, Inovio's Director of Corporate Communications.... 7/8/2008 3:04:00 PMInovio Biomedical Corporation54.0000FinalInovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement TranscriptINO9:00am ETTranscriptT1895592Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/bir/420454bir/420454normInovio Biomedical Corp.Genetronics Biomedical Ltd.Inovio ASGenetronics Biomedical Corp.United StatesManufacturing: Electroporation research systems for scientific laboratory use. Finance: Holding company.3841671933911255111217ACINO4/10/2008 6:16:00 AM420454Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/T1749823ccbn/T1749823norm1/29/2008 4:05:00 PMInovio Biomedical Corporation54.0000FinalInovio Biomedical Corporation Conference Call to update about the SECTA program and the clinical trials that are underway with DNA vaccines TranscriptINO9:00am ET...(Audio already in progress) -- Additional information concerning the numerous factors that could cause such differences in actual results or outcomes are contained in the Company's SEC filings which are available for review on the SEC's website or from the Company's website. Investors are encouraged to carefully review the Company's SEC filings for an understanding of the risks the Company faces and the factors which influence its results. I'd now like to turn the call over to Dr. Avtar Dhillon. ... TranscriptT1749823Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/22218srp/22218norm...Address:##### Sorrento Valley Road, San Diego, California #####-#### Incorporated:DelawareWeb Site: www.genetronics.comSIC Classification: Surgical and Medical Instruments and Apparatus (####) Business Description: Inovio Biomedical Corporation is a biomedical company developing drug and gene delivery systems that use Electroporation Therapy to deliver drugs and genes into cells. The company is developing and commercializing novel medical therapies based on electroporation, addressing critical unmet treatment needs. ... 2221845773H102INO10/6/2006 12:15:00 PM22218Credit & Investment ResearchSharkRepellent.net